retatrutide clinical trial access Eli Lilly infiltrates anti-obesity market as Phase III for begins Retatrutide just delivered the first

NHS access to Mounjaro has begun through primary care, but eligibility criteria are strict, and the rollout is phased over 12 years

Retatrutide is an experimental peptide currently being studied for its ability to help patients lose weight, improve blood sugar levels, and support overall metabolic health

Research Use Disclaimer

GLP-1 agonist tirzepatide and oral contraceptives The UKs MHRA recently issued guidance reminding patients using the GLP-1 agonist tirzepatide, who are also on oral contraceptives, that a barrier form of contraception should also be used

Lawes CM, Vander Hoorn S, Rodgers A, et al

Finally, the important but less common outcome of nonfatal stroke was reduced with GLP-1RA, particularly in the Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) 6 trial (semaglutide once weekly injection) and Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND